Twin pair analysis uncovers links between DNA methylation, mitochondrial DNA quantity and obesity

Aino Heikkinen, Vivienne F. C. Esser, Seung Hyuk Lee, Sara Lundgren, Antti Hakkarainen, Jesper Lundbom, Juho Kuula, Per‐Henrik Groop, Sini Heinonen, Sergio Villicaña, Jordana T. Bell, Alice Maguolo, Emma Nilsson, Charlotte Ling, Allan Vaag, Päivi Pajukanta, Jaakko Kaprio, Kirsi H. Pietiläinen, Shuai Li, Miina OllikainenNature Communications 2025 · DOI

TL;DR

This study reveals a fascinating link between mitochondrial DNA quantity (mtDNAq) and DNA methylation in adipose tissue, specifically at the SH3BP4 gene. The findings suggest that changes in mtDNAq might influence DNA methylation, which in turn affects gene expression, and that these processes are intertwined with obesity and insulin sensitivity.

What Problem Does This Paper Address?

Mitochondria, the powerhouses of our cells, are crucial for energy metabolism. Obesity is known to be associated with impaired mitochondrial function, but the precise molecular mechanisms connecting mitochondrial health, nuclear DNA methylation, and obesity remain unclear. This paper aims to untangle this complex relationship by investigating how mitochondrial DNA quantity (mtDNAq) and nuclear DNA methylation in key tissues (adipose and muscle) are linked to obesity-related traits. Understanding these connections could shed light on the development of metabolic diseases.

Methods

The researchers employed a multi-pronged approach:

  • Epigenome-Wide Association Study (EWAS): They scanned the entire genome for DNA methylation sites (CpGs) associated with mtDNAq in adipose and muscle tissue.
  • Correlation Analysis: They examined the relationship between DNA methylation at specific sites and the expression levels of nearby genes.
  • Causal Inference (ICE FALCON): This sophisticated statistical method, leveraging twin data, was used to infer the direction of causality between mtDNAq, DNA methylation, and obesity-related traits. It helps distinguish between cause and effect, and identify potential familial confounding.
  • Validation Studies: Findings were replicated in independent cohorts (TwinsUK and a Scandinavian T2D-discordant twin cohort) to ensure robustness.

Datasets

The study primarily utilized data from the Finnish Twin Cohort study (FTC), specifically a subcohort of 173 individuals (86 full twin pairs and 1 singleton). For validation, they used data from:

  • TwinsUK: A large UK twin registry.
  • Scandinavian T2D-discordant monozygotic twin cohort: A cohort of twins where one twin has type 2 diabetes and the other does not.

Key Insights and Ideas

  • Mitochondria-to-Nucleus Signaling: The study provides evidence for a potential "retrograde signaling" pathway where changes in mitochondrial DNA quantity (mtDNAq) might influence nuclear DNA methylation. This challenges the traditional view of a one-way street from nucleus to mitochondria.
  • SH3BP4 as a Key Player: A specific DNA methylation site (CpG) in the SH3BP4 gene in adipose tissue was strongly associated with mtDNAq. SH3BP4 is involved in intracellular signaling pathways and has been implicated in regulating cell growth and adipogenesis.
  • Interplay with Obesity Traits: A significant number of obesity-related traits, particularly those related to body fat composition and insulin sensitivity, were associated with both mtDNAq and SH3BP4 methylation. This highlights the intricate connection between cellular energy status, epigenetic regulation, and metabolic health.
  • Tissue Specificity: The observed associations were primarily found in adipose tissue, suggesting that the interplay between mtDNAq and DNA methylation might be tissue-specific, with adipose tissue playing a more prominent role in obesity-related metabolic changes compared to muscle.

Key Results

  • One CpG site at the SH3BP4 locus in adipose tissue showed a significant inverse association with mtDNAq (FDR < 0.05).
  • SH3BP4 methylation positively correlated with its gene expression.
  • 14 out of 35 obesity-related traits were significantly associated with both mtDNAq and SH3BP4 methylation in adipose tissue.
  • Causal inference analysis suggested that mtDNAq, insulin sensitivity, and certain body fat measures might causally influence SH3BP4 methylation.
  • Conversely, mtDNAq might causally influence obesity-related traits, though unmeasured confounding cannot be ruled out.

Limitations and Future Work

The authors acknowledge several limitations:

  • Cross-sectional Study Design: The study's cross-sectional nature limits definitive causal conclusions, although the ICE FALCON analysis helps infer causality.
  • Sample Size: The relatively modest sample size, particularly for certain analyses, may have limited statistical power.
  • Unmeasured Confounders: Factors like dietary habits were not fully accounted for, which could influence the observed associations.
  • Generalizability: The findings might not directly apply to individuals with severe health conditions, as the cohort primarily consisted of participants without such issues.

Future work could focus on:

  • Longitudinal Studies: To better understand the temporal dynamics of these relationships.
  • Mechanistic Studies: To elucidate the precise molecular pathways linking mtDNAq, DNA methylation, and SH3BP4 in obesity.
  • Intervention Studies: To explore whether modulating mtDNAq or SH3BP4 methylation can impact obesity-related phenotypes.
  • Exploring Other Tissues: While adipose tissue was key, further investigation into other tissues might reveal additional insights.

Summary updated

Abstract

Alterations in mitochondrial metabolism in obesity may indicate disrupted communication between mitochondria and nucleus, and DNA methylation may influence this interplay. Here, we leverage data from the Finnish Twin Cohort study subcohort (n = 173; 86 full twin pairs, 1 singleton), including comprehensive measurements of obesity-related outcomes, mitochondrial DNA quantity and nuclear DNA methylation levels in adipose and muscle tissue, to identify one CpG at SH3BP4 significantly associated with mitochondrial DNA quantity in adipose tissue (FDR < 0.05). We also show that SH3BP4 methylation correlates with its gene expression. Additionally, we find that 14 out of the 35 obesity-related traits display significant associations with both SH3BP4 methylation and mitochondrial DNA quantity in adipose tissue. We use data from TwinsUK and the Scandinavian T2D-discordant monozygotic twin cohort, to validate the observed associations. Further analysis using ICE FALCON suggests that mitochondrial DNA quantity, insulin sensitivity and certain body fat measures are causal to SH3BP4 methylation. Examining mitochondrial DNA quantity and obesity-related traits suggests causation from mitochondrial DNA quantity to obesity, but unmeasured within-individual confounding cannot be ruled out. Our findings underscore the impact of mitochondrial DNA quantity on DNA methylation and expression of the SH3BP4 gene within adipose tissue, with potential implications for obesity.
BibTeX
@inproceedings{heikkinen2025twin,
  author = {Aino Heikkinen and Vivienne F. C. Esser and Seung Hyuk Lee and Sara Lundgren and Antti Hakkarainen and Jesper Lundbom and Juho Kuula and Per‐Henrik Groop and Sini Heinonen and Sergio Villicaña and Jordana T. Bell and Alice Maguolo and Emma Nilsson and Charlotte Ling and Allan Vaag and Päivi Pajukanta and Jaakko Kaprio and Kirsi H. Pietiläinen and Shuai Li and Miina Ollikainen},
  title = {{Twin pair analysis uncovers links between DNA methylation, mitochondrial DNA quantity and obesity}},
  booktitle = {Nature Communications},
  year = {2025},
  doi = {10.1038/s41467-025-59576-7},
}
Figure